An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Overview
This bill proposes to eliminate the tax deduction currently available to pharmaceutical companies for marketing their products directly to consumers. The goal is to reduce the financial incentives for promoting prescription drugs to individuals rather than healthcare providers. By removing this deduction, the state aims to shift the focus towards more responsible and evidence-based healthcare decisions. This legislation seeks to address concerns about the influence of direct-to-consumer advertising on pharmaceutical sales and patient choices.
Key provisions
- Eliminates the tax deduction for direct-to-consumer pharmaceutical marketing.
- Applies to all pharmaceutical companies operating within the state.
- Seeks to reduce the financial incentives for promoting prescription drugs to consumers.
- Aims to shift the focus of pharmaceutical marketing towards healthcare professionals.
- The bill is intended to generate revenue for the state.
Who is affected
- Pharmaceutical companies
- Healthcare providers
- Consumers
- The State of Massachusetts
Notable changes
- This bill represents a significant change in state policy regarding pharmaceutical marketing.
- It mirrors previous attempts to address this issue through legislation.
- The elimination of the tax deduction could impact pharmaceutical company budgets and marketing strategies.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
3 on record
Primary sponsor
Cosponsors
Rebecca L. Rausch
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours